 Maria Cavasin
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Remodeling | 13 | 2021 | 225 | 1.450 |
Why?
| | Histone Deacetylases | 7 | 2018 | 196 | 0.970 |
Why?
| | Myocardial Infarction | 8 | 2022 | 931 | 0.830 |
Why?
| | Oligopeptides | 5 | 2010 | 248 | 0.810 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2021 | 142 | 0.780 |
Why?
| | Histone Deacetylase Inhibitors | 6 | 2021 | 199 | 0.700 |
Why?
| | Myocardium | 14 | 2022 | 926 | 0.680 |
Why?
| | Hypertension, Pulmonary | 5 | 2021 | 1749 | 0.570 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2014 | 36 | 0.480 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.480 |
Why?
| | Angiotensin II | 7 | 2021 | 91 | 0.470 |
Why?
| | Rats | 17 | 2022 | 5034 | 0.450 |
Why?
| | Rats, Sprague-Dawley | 11 | 2019 | 2262 | 0.440 |
Why?
| | Heart | 4 | 2007 | 608 | 0.430 |
Why?
| | Myocytes, Cardiac | 9 | 2022 | 457 | 0.400 |
Why?
| | Cell Proliferation | 4 | 2021 | 2194 | 0.390 |
Why?
| | Blood Pressure | 10 | 2022 | 1537 | 0.390 |
Why?
| | Cardiomegaly | 4 | 2016 | 161 | 0.390 |
Why?
| | Kidney | 5 | 2022 | 1207 | 0.380 |
Why?
| | Testosterone | 2 | 2005 | 337 | 0.380 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2021 | 420 | 0.370 |
Why?
| | Heart Ventricles | 6 | 2021 | 712 | 0.360 |
Why?
| | Endothelin Receptor Antagonists | 1 | 2010 | 58 | 0.350 |
Why?
| | Animals | 35 | 2022 | 32102 | 0.340 |
Why?
| | Thymosin | 2 | 2006 | 5 | 0.330 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2004 | 180 | 0.320 |
Why?
| | Hemodynamics | 3 | 2018 | 968 | 0.310 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 238 | 0.310 |
Why?
| | Heart Failure | 6 | 2022 | 1964 | 0.300 |
Why?
| | Vascular Remodeling | 2 | 2021 | 151 | 0.290 |
Why?
| | Serine Endopeptidases | 2 | 2007 | 102 | 0.290 |
Why?
| | Fibrosis | 7 | 2022 | 457 | 0.290 |
Why?
| | Mice, Inbred C57BL | 10 | 2022 | 4773 | 0.290 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2007 | 29 | 0.280 |
Why?
| | Mice | 21 | 2022 | 15052 | 0.270 |
Why?
| | Transcription Factors | 3 | 2019 | 1528 | 0.250 |
Why?
| | Disease Models, Animal | 11 | 2022 | 3580 | 0.250 |
Why?
| | Kidney Cortex | 1 | 2004 | 23 | 0.240 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2018 | 366 | 0.230 |
Why?
| | Antihypertensive Agents | 3 | 2010 | 432 | 0.220 |
Why?
| | Pulmonary Artery | 2 | 2021 | 1031 | 0.220 |
Why?
| | Collagen | 7 | 2007 | 415 | 0.210 |
Why?
| | Liver | 1 | 2010 | 1690 | 0.200 |
Why?
| | Myofibrils | 1 | 2022 | 46 | 0.200 |
Why?
| | Sarcomeres | 1 | 2022 | 89 | 0.200 |
Why?
| | Ramipril | 2 | 2001 | 4 | 0.200 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2021 | 239 | 0.200 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 124 | 0.190 |
Why?
| | Tetrazoles | 2 | 2001 | 32 | 0.190 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.190 |
Why?
| | Heart Murmurs | 1 | 2021 | 11 | 0.190 |
Why?
| | Angiotensin I | 1 | 2000 | 4 | 0.190 |
Why?
| | Imidazoles | 2 | 2001 | 217 | 0.180 |
Why?
| | Extracellular Matrix | 2 | 2021 | 439 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2022 | 3914 | 0.180 |
Why?
| | Male | 23 | 2022 | 55967 | 0.170 |
Why?
| | Estradiol | 1 | 2003 | 452 | 0.170 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 503 | 0.170 |
Why?
| | Reperfusion Injury | 1 | 2022 | 254 | 0.170 |
Why?
| | Regional Blood Flow | 2 | 2012 | 414 | 0.170 |
Why?
| | Hypertension | 4 | 2011 | 1064 | 0.160 |
Why?
| | Cardiomyopathies | 1 | 2022 | 303 | 0.160 |
Why?
| | Thermogenesis | 1 | 2018 | 40 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 116 | 0.150 |
Why?
| | Drug Discovery | 2 | 2016 | 124 | 0.150 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 68 | 0.150 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 124 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 388 | 0.140 |
Why?
| | Tryptophan Hydroxylase | 1 | 2016 | 52 | 0.140 |
Why?
| | Hypoxia | 2 | 2013 | 937 | 0.130 |
Why?
| | Fatty Liver | 1 | 2018 | 217 | 0.130 |
Why?
| | Enzyme Inhibitors | 3 | 2016 | 757 | 0.130 |
Why?
| | Chromatin | 1 | 2019 | 429 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 251 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 646 | 0.120 |
Why?
| | Protease Inhibitors | 2 | 2007 | 101 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2019 | 594 | 0.120 |
Why?
| | Fibroblasts | 2 | 2022 | 839 | 0.120 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 28 | 0.120 |
Why?
| | Captopril | 2 | 2004 | 11 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2004 | 56 | 0.120 |
Why?
| | Ovariectomy | 2 | 2005 | 117 | 0.120 |
Why?
| | Mice, Knockout | 6 | 2021 | 2604 | 0.110 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2004 | 117 | 0.110 |
Why?
| | Muscular Atrophy | 1 | 2014 | 74 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2013 | 27 | 0.110 |
Why?
| | Histone Deacetylase 6 | 3 | 2022 | 19 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 235 | 0.100 |
Why?
| | Calcinosis | 1 | 2014 | 242 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2014 | 230 | 0.100 |
Why?
| | Benzamides | 1 | 2012 | 168 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 659 | 0.090 |
Why?
| | Portal Pressure | 1 | 2010 | 6 | 0.090 |
Why?
| | Hepatic Stellate Cells | 1 | 2010 | 10 | 0.090 |
Why?
| | Connectin | 2 | 2022 | 30 | 0.090 |
Why?
| | Receptor, Endothelin B | 1 | 2010 | 51 | 0.090 |
Why?
| | Receptor, Endothelin A | 1 | 2010 | 59 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2353 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 362 | 0.090 |
Why?
| | Hypertension, Portal | 1 | 2010 | 62 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2013 | 701 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 488 | 0.080 |
Why?
| | Piperidines | 1 | 2010 | 163 | 0.080 |
Why?
| | Pyrimidines | 1 | 2012 | 376 | 0.080 |
Why?
| | Endothelin-1 | 1 | 2010 | 167 | 0.080 |
Why?
| | Sex Factors | 2 | 2022 | 1737 | 0.080 |
Why?
| | Nephrosclerosis | 1 | 2008 | 6 | 0.080 |
Why?
| | Pyridines | 1 | 2012 | 425 | 0.080 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 43 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 262 | 0.080 |
Why?
| | Macrophages | 5 | 2008 | 1284 | 0.080 |
Why?
| | Heart Rate | 4 | 2007 | 701 | 0.080 |
Why?
| | Female | 10 | 2022 | 59931 | 0.080 |
Why?
| | Histones | 1 | 2013 | 540 | 0.080 |
Why?
| | Indoles | 2 | 2014 | 309 | 0.070 |
Why?
| | Glomerular Mesangium | 1 | 2007 | 17 | 0.070 |
Why?
| | Random Allocation | 2 | 2008 | 337 | 0.070 |
Why?
| | Stroke Volume | 3 | 2014 | 509 | 0.070 |
Why?
| | Arginine Vasopressin | 1 | 2007 | 46 | 0.070 |
Why?
| | Substance P | 1 | 2007 | 44 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2004 | 59 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 447 | 0.070 |
Why?
| | Chronic Disease | 2 | 2004 | 1598 | 0.070 |
Why?
| | Time Factors | 5 | 2014 | 6165 | 0.070 |
Why?
| | Heart Rupture | 2 | 2004 | 4 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2021 | 3023 | 0.070 |
Why?
| | Azepines | 2 | 2019 | 74 | 0.070 |
Why?
| | Castration | 1 | 2005 | 14 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2517 | 0.070 |
Why?
| | Hydroxamic Acids | 2 | 2018 | 80 | 0.070 |
Why?
| | Ventricular Function, Left | 2 | 2014 | 467 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2017 | 274 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 549 | 0.060 |
Why?
| | Rupture | 1 | 2005 | 95 | 0.060 |
Why?
| | Triazoles | 2 | 2019 | 132 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1436 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1447 | 0.060 |
Why?
| | Hydroxyproline | 1 | 2004 | 22 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2019 | 526 | 0.060 |
Why?
| | Thiazolidines | 1 | 2004 | 7 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 95 | 0.060 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2004 | 3 | 0.060 |
Why?
| | Growth Inhibitors | 1 | 2004 | 45 | 0.060 |
Why?
| | Dipeptides | 1 | 2004 | 49 | 0.060 |
Why?
| | Humans | 12 | 2022 | 115611 | 0.060 |
Why?
| | Proline | 1 | 2004 | 72 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1646 | 0.060 |
Why?
| | Thiazoles | 1 | 2004 | 110 | 0.060 |
Why?
| | Organ Specificity | 1 | 2004 | 273 | 0.060 |
Why?
| | Nitriles | 1 | 2004 | 152 | 0.060 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 605 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 150 | 0.050 |
Why?
| | Orchiectomy | 1 | 2003 | 57 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2022 | 147 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 156 | 0.050 |
Why?
| | Acute Disease | 1 | 2004 | 914 | 0.050 |
Why?
| | Elastic Modulus | 1 | 2022 | 118 | 0.050 |
Why?
| | Survival Rate | 1 | 2005 | 1650 | 0.050 |
Why?
| | Receptors, Bradykinin | 1 | 2001 | 4 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2022 | 115 | 0.050 |
Why?
| | Cytoprotection | 1 | 2001 | 53 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2013 | 339 | 0.050 |
Why?
| | Protein Binding | 2 | 2019 | 1917 | 0.050 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 446 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2001 | 77 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 113 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2022 | 299 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 867 | 0.040 |
Why?
| | Cardiac Output | 1 | 2000 | 143 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2004 | 641 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 279 | 0.040 |
Why?
| | Organ Size | 1 | 2000 | 434 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1001 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 275 | 0.040 |
Why?
| | Systole | 2 | 2014 | 169 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 832 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 263 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 168 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 150 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 33 | 0.040 |
Why?
| | Echocardiography | 1 | 2000 | 559 | 0.040 |
Why?
| | Inflammation | 2 | 2008 | 2499 | 0.040 |
Why?
| | Myosins | 1 | 2018 | 126 | 0.040 |
Why?
| | Signal Transduction | 3 | 2017 | 4541 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2014 | 962 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 225 | 0.040 |
Why?
| | RNA Polymerase II | 1 | 2019 | 283 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 285 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2016 | 52 | 0.030 |
Why?
| | Hydrogels | 1 | 2022 | 581 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 81 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 780 | 0.030 |
Why?
| | Serotonin | 1 | 2016 | 296 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 602 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 31 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 81 | 0.030 |
Why?
| | Simvastatin | 1 | 2014 | 59 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 736 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 476 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 715 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 281 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 42 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 129 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 317 | 0.020 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 1724 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 546 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 341 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 588 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 186 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1078 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1083 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 438 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 544 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2800 | 0.020 |
Why?
| | Albuminuria | 1 | 2008 | 164 | 0.020 |
Why?
| | Probability | 1 | 2008 | 294 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6419 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 744 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1700 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 27014 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1153 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2007 | 283 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2004 | 38 | 0.010 |
Why?
| | Renal Circulation | 1 | 2004 | 53 | 0.010 |
Why?
| | Infant | 1 | 2017 | 7975 | 0.010 |
Why?
| | Connective Tissue Growth Factor | 1 | 2004 | 21 | 0.010 |
Why?
| | Lung | 1 | 2016 | 3673 | 0.010 |
Why?
| | Cell Movement | 1 | 2008 | 867 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1642 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 53 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1718 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2004 | 102 | 0.010 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2004 | 103 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 213 | 0.010 |
Why?
| | Mast Cells | 1 | 2004 | 117 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2003 | 32 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2003 | 41 | 0.010 |
Why?
| | Diastole | 1 | 2003 | 134 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 350 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 1970 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 759 | 0.010 |
Why?
| | Receptor, Bradykinin B2 | 1 | 2001 | 2 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2001 | 8 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2001 | 21 | 0.010 |
Why?
| | Monocytes | 1 | 2004 | 507 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 399 | 0.010 |
Why?
| | Aged | 1 | 2018 | 19255 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17903 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1172 | 0.010 |
Why?
| | Child | 1 | 2017 | 18486 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1356 | 0.010 |
Why?
| | Adult | 1 | 2018 | 30726 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 2418 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 3467 | 0.010 |
Why?
|
|
Cavasin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|